S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Section

Market Quotes

Found 8824 articles

Market Quotes

MapLight’s Autism Drug Misses Primary Goal in Mid-Stage Trial

A mid-stage clinical trial for MapLight Therapeutics’ experimental autism drug, ML-004, failed to meet its primary objective of improving social communication. Despite the setback for the lead candidate, the company reported a positive signal in reducing irritability among adolescents, potentially opening a new regulatory pathway for the treatment.

Market Quotes

Daniel Krawczyk Tapped to Lead Rayonier Advanced Materials

Daniel Krawczyk has been appointed chief executive of Rayonier Advanced Materials, stepping into the role as the company navigates a high-stakes strategic review. He replaces Scott Sutton, who resigned in April, ending a period where the firm was steered by an interim office of four executives.

Market Quotes

Outdoor Holding Trims Losses as GunBroker Platform Gains Traction

A sharp pivot in profitability saw Outdoor Holding trim its quarterly loss to $1.48 million, down from a staggering $78.3 million deficit during the same period last year. The hunting-products firm clawed back ground as revenue rose 10% to $13.9 million, fueled by a resurgence in its core digital marketplace.

Market Quotes

Definium Therapeutics Surges After Depression Drug Hits Phase 3 Goals

Shares of Definium Therapeutics climbed 50% to $36.74 in premarket trading Monday, fueled by positive late-stage clinical data for its experimental depression treatment, DT120. The company reported that the Emerge study achieved its primary and secondary endpoints, signaling a potential shift in how major depressive disorder is managed.

Market Quotes

Booz Allen Hamilton Snaps Up Cobham Ultra Unit for $720 Million

With $720 million in cash, Booz Allen Hamilton is absorbing the defense-technology arm of Cobham Ultra Group, a strategic play to integrate specialized encryption and edge-computing capabilities into its national security portfolio as the demand for software-driven battlefield systems intensifies across global defense markets.

Market Quotes

Canadian Antitrust Watchdog Escalates Grocery Lease Probe

Canada's Competition Bureau has secured court orders compelling grocery giant Empire to surrender internal documents and provide oral testimony. The move signals a sharpened focus on commercial lease agreements suspected of stifling market competition and inflating consumer costs across the country's retail food sector.

Market Quotes

CVS Health Lowers Barriers to GLP-1 Weight-Loss Drugs

Starting July 1, CVS Health will integrate into the federal Medicare GLP-1 Bridge program, capping monthly costs at $50 for eligible beneficiaries through 2027. This move marks a significant pivot for the pharmacy giant as it seeks to stabilize access to high-demand weight-loss medications amid soaring out-of-pocket expenses.

Market Quotes

Regeneron Advances Cemdisiran for Myasthenia Gravis Treatment

Regeneron Pharmaceuticals has secured regulatory traction for cemdisiran, as both the FDA and European Medicines Agency accepted applications to treat adults suffering from generalized myasthenia gravis. The drug candidate, developed in partnership with Alnylam Pharmaceuticals, targets patients who are anti-acetylcholine receptor antibody-positive, marking a significant step in managing the chronic autoimmune condition.

Market Quotes

AbbVie Eyes $10.9 Billion Acquisition of Apogee Therapeutics

A potential $10.9 billion cash deal is driving Apogee Therapeutics shares to a 53% surge in premarket trading. According to reports, AbbVie is closing in on the acquisition of the Waltham-based biotechnology firm, signaling a significant expansion of its clinical-stage pipeline at a 60% premium over recent market valuations.

Market Quotes

Getty Images Stock Surges 171% on OpenAI Content Deal

A 171% leap in premarket trading on Monday rescued Getty Images from a brutal year, as shares climbed to $1.64 following the announcement of a strategic partnership with OpenAI. The sudden rally marks a significant reversal for the company, which had seen its market value halved since January.

Market Quotes

MoonLake Shares Rally on Sonelokimab Trial Results

A 22% premarket surge greeted MoonLake Immunotherapeutics on Monday after the company reported that its experimental skin treatment, sonelokimab, maintained and deepened clinical improvements over a 52-week trial period for patients suffering from moderate-to-severe hidradenitis suppurativa.

Market Quotes

Valens Semiconductor Appoints Karine Pinto-Flomenboim as CFO

Karine Pinto-Flomenboim is joining Valens Semiconductor as its new chief financial officer, bringing experience from her previous role at Arbe Robotics. She is set to assume the position at the Hod Hasharon-based chipset manufacturer on August 9, filling a vacancy left by the departure of Guy Nathanzon.

Market Quotes

Nextpower Targets European Solar Growth With $379 Million Acquisition

Nextpower has agreed to acquire Zimmermann PV-Steel Group for approximately $378.6 million in a cash-and-stock deal designed to scale its solar-technology footprint. The transaction, slated to close in the second half of fiscal 2027, adds four product lines and extends the company’s operational reach into 15 new countries.

Market Quotes

Regenxbio Surges as FDA Reverses Course on Rare Disease Therapy

Regenxbio shares climbed 12% to $8.75 in premarket trading following reports that the Food and Drug Administration will reconsider its rejection of the company’s experimental gene therapy. The shift follows a regulatory impasse regarding Navsunli, a treatment intended for patients suffering from the fatal, rare condition known as Hunter syndrome.

Market Quotes

Merck Reports Positive Phase 3 Results for Tulisokibart

Twelve weeks into a pivotal clinical trial, Merck & Co.’s experimental drug tulisokibart successfully induced clinical remission in patients suffering from moderately to severely active ulcerative colitis. The Rahway-based pharmaceutical giant confirmed the study met both its primary objective and critical secondary endpoints for the autoimmune treatment.

Market Quotes

Asian Markets Rally as Middle East Tensions Ease

A tentative diplomatic breakthrough between Washington and Tehran has calmed regional anxiety, even as oil prices remain erratic. While U.S. and Iranian officials work toward ending military operations in Lebanon, investors are pivoting back to risk-on assets, propelling Japan’s Nikkei to a record closing high on Monday.

Market Quotes

Global Markets Tread Water as Energy Prices Slip

A retreat in oil prices and a quiet start for U.S. futures defined early trading, while investors navigated a fragmented landscape across Europe and Asia. Brent crude shed 1.6% to settle at $79.25 a barrel, dragging on energy sentiment even as regional benchmarks staged localized rallies in response to individual corporate earnings.

Market Quotes

Danone Expands Asia-Pacific Footprint With MADE Group Acquisition

Danone has moved to solidify its presence in the Asia-Pacific nutrition market by acquiring Australia-based MADE Group. This strategic purchase of the health-food producer, which specializes in high-protein drinks and coconut-based snacks, marks a significant step in the French giant's regional expansion strategy.

Market Quotes

Asian Markets Waver as U.S.-Iran De-escalation Talks Face Scrutiny

A volatile diplomatic climate between Washington and Tehran has left Asian markets scrambling for direction, as fresh threats from the U.S. president clash with assurances from mediators in Pakistan and Qatar that a mechanism to halt military operations in Lebanon remains on the table.

Market Quotes

Australia and Canada Finalize $1.75 Billion Arctic Radar Pact

Canada has secured a $1.75 billion deal for Australia’s cutting-edge over-the-horizon radar technology, a move designed to bolster North American defense against low-flying missile threats. The agreement represents Australia’s largest-ever defense export and marks the first time this high-frequency system has been sold to an international partner.

Market Quotes

Asahi Co. Profits Slip in First Quarter Despite Revenue Growth

A 2.5 percent climb in revenue to 27.79 billion yen was not enough to shield Asahi Co. from a bottom-line contraction this spring. For the first quarter ended May 20, the Japanese firm reported a net profit of 2.14 billion yen, falling short of the 2.34 billion yen recorded during the same period last year.

Market Quotes

Australia Secures Record $1.75 Billion Defense Export to Canada

Canada has finalized a $1.75 billion agreement to acquire Australia’s sophisticated over-the-horizon radar system, marking the largest defense export in Australian history. This strategic purchase aims to bolster North American aerospace defenses by tracking low-flying missiles across the Arctic that remain invisible to conventional radar due to the Earth's curvature.

Market Quotes

Three Chinese Tech Firms Seek $270 Million in Hong Kong IPOs

With Beijing backing high-tech industrial growth, three Chinese manufacturers are tapping the Hong Kong equity market for a combined $270 million. Zhejiang Laifual Drive, Guangdong True Health Medical Technology, and Jiangxi Institute of Biological Products are all pricing their shares this week, aiming to conclude their offerings by June 25.

Market Quotes

Alamos Gold Shares Slide as Seismic Events Hit Ontario Output

Shares of Alamos Gold dropped 18% Friday morning to 41.92 Canadian dollars, following an announcement that a series of seismic events and regional power failures have forced the company to lower its production outlook for both the second quarter and the full fiscal year.

Market Quotes

Couche-Tard Earnings Preview: Fuel Costs and U.S. Consumer Spending

High fuel prices loom over Alimentation Couche-Tard’s fourth-quarter results as investors weigh whether rising transaction fees and stretched consumer budgets will dampen the convenience-store operator's bottom line. Analysts expect a revenue climb to $18.51 billion when the company reports its figures after Monday’s market close.

Market Quotes

Gulf Oil Producers Pivot to Logistics After Strait of Hormuz Reopening

The Strait of Hormuz is finally seeing movement again, but the resumption of transit follows a brutal four-month closure that choked global oil supplies. As tankers tentatively return to the waterway, Gulf producers now face the grueling task of clearing massive shipping bottlenecks and restoring prewar export capacity.

Market Quotes

Asian Central Banks Tighten Policy as Inflationary Pressures Persist

As global markets react to the U.S.-Iran peace deal, Asian central banks are bucking the global trend of caution. While counterparts in the U.S. and Europe hold steady, authorities in Japan, Indonesia, and the Philippines have aggressively raised rates to defend their currencies and contain the lingering effects of the energy shock.

Market Quotes

MDA Space Targets US Defense Market with $620 Million Buyout

Canada's MDA Space is acquiring Colorado-based Blue Canyon Technologies for $620 million in an all-cash deal, marking a aggressive push into the lucrative U.S. defense sector. The agreement, expected to close by year-end, grants the Canadian firm an immediate manufacturing foothold and entry into critical government supply chains.

Market Quotes

Temasek Names Mapletree Executive Wendy Koh as New CFO

Singapore state-owned investor Temasek Holdings has tapped Wendy Koh to oversee its global finances, marking a strategic leadership shuffle within its corporate ecosystem. Koh, currently serving as group CFO at the Temasek-owned real estate firm Mapletree Investments, will transition into her new role this autumn to succeed outgoing finance chief Png Chin Yee.

Market Quotes

Indian IT Giants Slide as Accenture Forecast Sparks AI Anxiety

A sharp 18% plunge in Accenture shares has sent shockwaves through the Indian software sector, reigniting investor fears that artificial intelligence is rapidly rendering traditional IT consulting obsolete. The sell-off, which dragged down major Indian firms on Friday, underscores deep-seated anxieties regarding long-term revenue viability in an era of rapid automation.